B. Metzler Seel. Sohn & Co. Ag Amgen Inc Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $10 Billion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Amgen Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 52,667 shares of AMGN stock, worth $14.7 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
52,667
Previous 50,793
3.69%
Holding current value
$14.7 Million
Previous $15.9 Million
6.93%
% of portfolio
0.17%
Previous 0.17%
Shares
12 transactions
Others Institutions Holding AMGN
# of Institutions
3,120Shares Held
410MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$14.6 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.17 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.1 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$3.97 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $149B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...